Newsfiscal.ai
BioCardia Announces FDA Acceptance of De Novo Pre-Submission Package for Helix™ Catheter
· Published
Article summary
BioCardia, Inc. announced that the FDA has accepted its pre-submission package for marketing clearance of the Helix catheter, a device intended for the delivery of therapeutic and diagnostic agents.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…